96 related articles for article (PubMed ID: 27553814)
1. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.
Lu Z; Su J; Li Z; Zhan Y; Ye D
Drug Dev Ind Pharm; 2017 Jan; 43(1):160-170. PubMed ID: 27553814
[TBL] [Abstract][Full Text] [Related]
2. Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia.
Kim DH; Guo Y; Zhang Z; Procissi D; Nicolai J; Omary RA; Larson AC
Adv Healthc Mater; 2014 May; 3(5):714-24. PubMed ID: 24574255
[TBL] [Abstract][Full Text] [Related]
3. Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models.
Tu MJ; Ho PY; Zhang QY; Jian C; Qiu JX; Kim EJ; Bold RJ; Gonzalez FJ; Bi H; Yu AM
Cancer Lett; 2019 Feb; 442():82-90. PubMed ID: 30389433
[TBL] [Abstract][Full Text] [Related]
4. Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy.
Sun J; Wan Z; Chen Y; Xu J; Luo Z; Parise RA; Diao D; Ren P; Beumer JH; Lu B; Li S
Acta Biomater; 2020 Apr; 106():289-300. PubMed ID: 32004652
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer.
Dora CP; Kushwah V; Yadav V; Kuche K; Jain S
Mol Pharm; 2024 Jun; 21(6):2699-2712. PubMed ID: 38747900
[TBL] [Abstract][Full Text] [Related]
6. Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations.
Yugatama A; Huang YL; Hsu MJ; Lin JP; Chao FC; Lam JKW; Hsieh CM
Int J Nanomedicine; 2024; 19():3753-3772. PubMed ID: 38686338
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.
Han NK; Shin DH; Kim JS; Weon KY; Jang CY; Kim JS
Int J Nanomedicine; 2016; 11():1413-25. PubMed ID: 27103799
[TBL] [Abstract][Full Text] [Related]
8. Thermosensitive polymer prodrug nanoparticles prepared by an all-aqueous nanoprecipitation process and application to combination therapy.
Guerassimoff L; Ferrere M; Van Herck S; Dehissi S; Nicolas V; De Geest BG; Nicolas J
J Control Release; 2024 May; 369():376-393. PubMed ID: 38554772
[TBL] [Abstract][Full Text] [Related]
9. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy.
Lin L; Fan Y; Gao F; Jin L; Li D; Sun W; Li F; Qin P; Shi Q; Shi X; Du L
Theranostics; 2018; 8(7):1923-1939. PubMed ID: 29556365
[TBL] [Abstract][Full Text] [Related]
10. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy.
Sun J; Chen Y; Xu J; Song X; Wan Z; Du Y; Ma W; Li X; Zhang L; Li S
Theranostics; 2020; 10(3):1136-1150. PubMed ID: 31938056
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study.
Sun S; Shang E; Ju A; Li Y; Wu Q; Li Q; Yang Y; Guo Y; Yang D; Lv S
Fitoterapia; 2021 Nov; 155():105033. PubMed ID: 34517057
[TBL] [Abstract][Full Text] [Related]
12. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
Yang C; Li C; Zhang P; Wu W; Jiang X
Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
[TBL] [Abstract][Full Text] [Related]
13. Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs.
Bartkowski M; Bincoletto V; Salaroglio IC; Ceccone G; Arenal R; Nervo S; Rolando B; Riganti C; Arpicco S; Giordani S
J Colloid Interface Sci; 2024 Apr; 659():339-354. PubMed ID: 38176243
[TBL] [Abstract][Full Text] [Related]
14. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
Hoque MM; Iida Y; Kotani H; Harada M
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
[TBL] [Abstract][Full Text] [Related]
15. Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer.
Uz M; Kalaga M; Pothuraju R; Ju J; Junker WM; Batra SK; Mallapragada S; Rachagani S
J Control Release; 2019 Jan; 294():237-246. PubMed ID: 30576747
[TBL] [Abstract][Full Text] [Related]
16. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging.
Affram K; Udofot O; Singh M; Krishnan S; Reams R; Rosenberg J; Agyare E
PLoS One; 2017; 12(9):e0185116. PubMed ID: 28934281
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.
Zhang J; Xiao X; Zhu J; Gao Z; Lai X; Zhu X; Mao G
Int J Nanomedicine; 2018; 13():3039-3051. PubMed ID: 29861635
[TBL] [Abstract][Full Text] [Related]
18. Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro.
Elechalawar CK; Hossen MN; Shankarappa P; Peer CJ; Figg WD; Robertson JD; Bhattacharya R; Mukherjee P
Int J Nanomedicine; 2020; 15():991-1003. PubMed ID: 32103952
[TBL] [Abstract][Full Text] [Related]
19. Co-Delivery of Gemcitabine and Honokiol by Lipid Bilayer-Coated Mesoporous Silica Nanoparticles Enhances Pancreatic Cancer Therapy via Targeting Depletion of Tumor Stroma.
Liu D; Wang L; Li H; Li D; Zhou J; Wang J; Zhang Q; Cai D
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338418
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic Acid-Conjugated Carbon Nanomaterials for Enhanced Tumour Targeting Ability.
Kearns O; Camisasca A; Giordani S
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
